Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qui Tran

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Blood|May 10, 2018
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomabMax S Topp, Zachary Zimmerman, Paul Cannell, et al.
BMC Medical Education|March 13, 2021
Cultural competence of Australian dental studentsRodrigo Mariño, Julie Satur, Eren Tuncer, et al.
Leukemia & Lymphoma|April 6, 2019
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemiaHervé Dombret, Max S Topp, Andre C Schuh, et al.
Blood Advances|June 30, 2018
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemiaAnthony S Stein, Richard A Larson, Andre C Schuh, et al.
American Journal of Hematology|June 23, 2021
Impact of Philadelphia chromosome-like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER studyElias Jabbour, Keyur Patel, Nitin Jain, et al.
Clinical Colorectal Cancer|May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal CancerLisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
Cancer|August 22, 2019
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 studyElias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, et al.
Asia-Pacific Journal of Clinical Oncology|June 29, 2021
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemiaYukio Kobayashi, Iekuni Oh, Toshihiro Miyamoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2025
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory <i>KRAS</i> G12C Colorectal CancerFilippo Pietrantonio, Lisa Salvatore, Taito Esaki, et al.
Nature Medicine|January 4, 2024
Sotorasib with panitumumab in chemotherapy-refractory KRAS<sup>G12C</sup>-mutated colorectal cancer: a phase 1b trialYasutoshi Kuboki, Marwan Fakih, John Strickler, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Blood|May 10, 2018
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomabMax S Topp, Zachary Zimmerman, Paul Cannell, et al.
BMC Medical Education|March 13, 2021
Cultural competence of Australian dental studentsRodrigo Mariño, Julie Satur, Eren Tuncer, et al.
Leukemia & Lymphoma|April 6, 2019
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemiaHervé Dombret, Max S Topp, Andre C Schuh, et al.
Blood Advances|June 30, 2018
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemiaAnthony S Stein, Richard A Larson, Andre C Schuh, et al.
American Journal of Hematology|June 23, 2021
Impact of Philadelphia chromosome-like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER studyElias Jabbour, Keyur Patel, Nitin Jain, et al.
Clinical Colorectal Cancer|May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal CancerLisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
Cancer|August 22, 2019
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 studyElias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, et al.
Asia-Pacific Journal of Clinical Oncology|June 29, 2021
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemiaYukio Kobayashi, Iekuni Oh, Toshihiro Miyamoto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2025
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory <i>KRAS</i> G12C Colorectal CancerFilippo Pietrantonio, Lisa Salvatore, Taito Esaki, et al.
Nature Medicine|January 4, 2024
Sotorasib with panitumumab in chemotherapy-refractory KRAS<sup>G12C</sup>-mutated colorectal cancer: a phase 1b trialYasutoshi Kuboki, Marwan Fakih, John Strickler, et al.
Pageof 5